MIF is highly expressed in head-and-neck cancer (HNC) and stimulates functions of neutrophils by enhancing their CXCR2-dependent recruitment and survival and release of CCL4 and MMP9, in turn, promoting tumor progression [188]. The gene discussed is CXCR2; the disease is neoplasm.